Results
920
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
920 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
DNP | zł303.30 | -3.3% | -18.0% | zł29.7b | zł400.38 | PE21x | E18.0% | n/a | Consumer Retailing | ||
DIA | €0.013 | -2.3% | -5.2% | €742.9m | n/a | PE-36.2x | E67.7% | 0% | Consumer Retailing | ||
VESBE | ₺17.38 | 2.5% | 8.4% | ₺27.5b | ₺31.05 | PE7.8x | E36.8% | 4.2% | Consumer Durables | ||
TOURN | SEK 8.26 | 3.3% | 3.5% | SEK 80.6m | SEK 13.00 | PB3.2x | E103.8% | n/a | Media | ||
300308 | CN¥115.94 | 8.9% | 68.2% | CN¥128.1b | CN¥168.08 | PE32.7x | E31.8% | 0.3% | Tech | ||
GMR | UK£0.38 | 0.8% | 4.8% | UK£112.0m | n/a | PE16.7x | E22.1% | n/a | Media | ||
GSY | CA$181.00 | 1.0% | 60.1% | CA$3.0b | CA$236.25 | PE11.5x | E17.1% | 2.6% | Diversified Financials | ||
EQT | US$33.27 | 3.6% | -18.8% | US$19.9b | US$40.87 | PE28.4x | E39.0% | 1.9% | Energy | ||
2222 | JP¥1,722.50 | -2.1% | -26.6% | JP¥268.1b | JP¥2,453.33 | PE24.3x | E12.8% | 1.6% | Food, Beverage & Tobacco | ||
RAJESHEXPO | ₹293.10 | -0.03% | -44.3% | ₹86.5b | ₹600.00 | PE227.6x | E40.1% | 0% | Consumer Durables | ||
300048 | CN¥4.36 | 1.6% | -15.5% | CN¥4.9b | n/a | PS2x | E108.3% | 0% | Capital Goods | ||
HSSEB | RM 1.08 | -0.9% | 44.0% | RM 549.2m | RM 1.49 | PE30.2x | E37.3% | 1.1% | Capital Goods | ||
VRTX | US$481.26 | 2.2% | 34.3% | US$126.3b | US$509.82 | PS12x | E46.4% | n/a | Pharmaceuticals & Biotech | ||
FRAN | UK£1.60 | -4.8% | 1.3% | UK£307.6m | UK£3.23 | PE101.3x | E63.3% | 1.4% | Commercial Services | ||
600989 | CN¥14.45 | 0.9% | 1.2% | CN¥106.0b | CN¥21.69 | PE15.8x | E31.9% | 1.9% | Materials | ||
CRC | US$52.60 | 9.9% | -8.4% | US$4.5b | US$62.29 | PE28.6x | E49.0% | 2.9% | Energy | ||
TRMK | US$32.67 | 4.0% | 52.0% | US$2.0b | US$37.60 | PB1.1x | E74.6% | 2.8% | Banks | ||
INF | UK£8.47 | 1.5% | 12.4% | UK£11.2b | UK£9.88 | PE35.8x | E21.5% | 2.2% | Media | ||
CTKB | US$5.34 | -4.5% | -16.8% | US$672.0m | US$8.70 | PS3.6x | E111.9% | n/a | Pharmaceuticals & Biotech | ||
CSB | R161.20 | 0.9% | -6.3% | R3.3b | R192.00 | PE40x | E63.9% | 2.9% | Retail | ||
HUSQ B | SEK 65.60 | -1.6% | -23.5% | SEK 37.5b | SEK 81.83 | PE22x | E26.0% | 4.6% | Capital Goods | ||
STIL | SEK 222.00 | 2.8% | 96.5% | SEK 2.0b | SEK 270.50 | PE41.7x | E34.4% | 0% | Healthcare | ||
PAHC | US$21.53 | 4.9% | 71.6% | US$890.7m | US$15.60 | PE360.9x | E51.5% | 2.2% | Pharmaceuticals & Biotech | ||
LITI | SEK 8.30 | 0% | -8.0% | SEK 137.7m | n/a | PE1199.8x | E111.3% | n/a | Software |